Bicycle Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	981	767	879	1,790	382	169
Market Cap Growth	66.06%	-12.72%	-50.89%	367.96%	126.52%	-
Enterprise Value	534	281	581	1,393	261	78
PE Ratio	-	-4.24	-7.80	-26.78	-7.50	-5.52
PS Ratio	22.88	28.43	60.76	152.99	36.81	12.23
PB Ratio	2.67	2.07	3.25	5.17	4.01	1.81
P/FCF Ratio	-12.34	-12.07	-8.36	-106.37	-20.14	-5.60
P/OCF Ratio	-12.46	-12.65	-10.21	-120.97	-21.50	-5.90
EV/Sales Ratio	12.83	10.40	40.16	119.08	25.16	5.65
EV/EBITDA Ratio	-4.10	-1.66	-5.42	-21.73	-5.23	-2.61
EV/EBIT Ratio	-3.94	-1.60	-5.24	-21.27	-5.10	-2.53
EV/FCF Ratio	-7.47	-4.42	-5.53	-82.79	-13.76	-2.58
Debt / Equity Ratio	0.11	0.11	0.15	0.12	0.16	0.01
Debt / EBITDA Ratio	-0.25	-0.24	-0.38	-0.65	-0.30	-0.04
Debt / FCF Ratio	-0.45	-0.63	-0.39	-2.49	-0.79	-0.04
Quick Ratio	10.02	7.92	6.76	12.43	6.51	11.25
Current Ratio	10.42	8.08	6.93	12.65	6.73	11.81
Asset Turnover	0.07	0.05	0.03	0.04	0.07	0.14
Interest Coverage	-49.81	-53.92	-33.16	-21.95	-112.20	-
Return on Equity (ROE)	-49.30%	-57.80%	-37.50%	-33.40%	-57.00%	-261.90%
Return on Assets (ROA)	-30.10%	-34.10%	-26.00%	-22.10%	-35.20%	-31.90%
Return on Capital (ROIC)	-45.55%	-46.21%	-37.39%	-16.90%	-47.07%	-27.84%
Earnings Yield	-17.66%	-23.56%	-12.83%	-3.73%	-13.34%	-18.13%
FCF Yield	-9.03%	-8.29%	-11.96%	-0.94%	-4.97%	-17.87%
Buyback Yield / Dilution	-41.86%	-20.00%	-18.35%	-30.90%	-73.34%	-2416.82%
Total Shareholder Return	-41.86%	-20.00%	-18.35%	-30.90%	-73.34%	-2416.82%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).